Hybrid bioprocess system for cell culture and purification

Integrates Upstream and Downstream Bioprocessing

The Hybrid Bioprocess System from AUSTAR seamlessly integrates stainless steel and single-use technologies to enhance both upstream and downstream bioprocessing. This flexible system is tailored for pharmaceutical, biopharmaceutical, and biotechnology firms, offering comprehensive solutions for processes such as media preparation, cell culture, and purification of biologics including monoclonal antibodies, vaccines, and insulin. With customizable configurations, this system supports automatic control and validation, ensuring optimized throughput and precision. Its hybrid design leverages the robustness of stainless steel and the adaptability of single-use components, providing cost-effective and scalable solutions. The system is compatible with cGMP standards and supports clean-in-place (CIP) protocols, minimizing maintenance downtime while maintaining strict sterility. Available engineering support and project management services ensure seamless integration into existing production lines, addressing diverse operational needs with precision and reliability.